Glycosidase

α-HNJNAc is a potent, competitive inhibitor of hexosaminidases, selectively targeting these enzymes while demonstrating no interference with other glycosidases. This specificity makes α-HNJNAc an invaluable tool for research applications focused on the modulation of glycan metabolism and the study of lysosomal storage disorders. Its ability to inhibit hexosaminidases can aid in unraveling the biochemical pathways involved in glucosamine metabolism and related enzymatic activities.

CHI3L1 binder 1 is a selective CHI3L1 inhibitor with a dissociation constant (Kd) of 182 µM. This compound is valuable for studying various biological processes, including immune response, tissue remodeling, and cancer progression. Its specificity for CHI3L1 makes it a useful tool for researchers investigating the role of this protein in disease mechanisms and therapeutic interventions.

CHI3L1-IN-1 is a selective inhibitor of Chitinase-3-like protein 1 (CHI3L1), also known as YKL-40, with an IC50 of 50 nM. This compound exhibits additional effects by inhibiting the hERG channel with an IC50 of 2.3 μM. CHI3L1-IN-1 is valuable for research applications focused on the roles of CHI3L1 in inflammation and cancer, offering insights into its potential as a biomarker and therapeutic target.